Published in Cell Growth Differ on September 01, 1990
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol (2001) 6.21
K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol (1993) 3.56
Analysis of the transcriptional program induced by Raf in epithelial cells. Genes Dev (2001) 2.56
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer (1991) 2.52
Neu differentiation factor activation of ErbB-3 and ErbB-4 is cell specific and displays a differential requirement for ErbB-2. Mol Cell Biol (1995) 1.63
Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A (1991) 1.52
Inhibition of PC cell-derived growth factor (PCDGF, epithelin/granulin precursor) expression by antisense PCDGF cDNA transfection inhibits tumorigenicity of the human breast carcinoma cell line MDA-MB-468. Proc Natl Acad Sci U S A (2000) 1.48
Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas. Br J Cancer (1994) 1.09
Blockade of the epidermal growth factor receptor tyrosine kinase suppresses tumorigenesis in MMTV/Neu + MMTV/TGF-alpha bigenic mice. Proc Natl Acad Sci U S A (2000) 1.08
Acquired MET expression confers resistance to EGFR inhibition in a mouse model of glioblastoma multiforme. Oncogene (2011) 1.07
Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Proc Natl Acad Sci U S A (1994) 1.07
Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors. EMBO J (1997) 1.04
Alterations of EGFR, p53 and PTEN that mimic changes found in basal-like breast cancer promote transformation of human mammary epithelial cells. Cancer Biol Ther (2013) 0.95
Ras p21 in breast tissue: associations with pathology and cellular localisation. Br J Cancer (1992) 0.93
Chronic activation of wild-type epidermal growth factor receptor and loss of Cdkn2a cause mouse glioblastoma formation. Cancer Res (2011) 0.85
Image analysis of the AgNOR response in ras-transformed human breast epithelial cells. Acta Histochem (2007) 0.78
IK channel activation increases tumor growth and induces differential behavioral responses in two breast epithelial cell lines. Oncotarget (2017) 0.75
Continuity and change in the social competence of children with autism, Down syndrome, and developmental delays. Monogr Soc Res Child Dev (1999) 5.05
A human colonic tumor cell line that maintains vectorial electrolyte transport. Am J Physiol (1984) 4.47
Biological profiles of highly potent novel endothelin antagonists selective for the ETA receptor. Life Sci (1992) 4.39
Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77
KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer. Br J Cancer (2009) 3.73
Subfragments of the large terminal repeat cause glucocorticoid-responsive expression of mouse mammary tumor virus and of an adjacent gene. Proc Natl Acad Sci U S A (1983) 3.42
Genetic control of diploid recovery after gamma-irradiation in the yeast Saccharomyces cerevisiae. Mutat Res (1980) 2.72
TRANCE, a TNF family member, activates Akt/PKB through a signaling complex involving TRAF6 and c-Src. Mol Cell (1999) 2.64
Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A (1994) 2.43
Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study. J Clin Endocrinol Metab (2015) 2.41
The growth of cells in serum-free hormone-supplemented media. Methods Enzymol (1979) 2.18
Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res (1984) 2.17
Growth of hybridoma cells in serum-free medium: ethanolamine is an essential component. Proc Natl Acad Sci U S A (1982) 2.17
Human P-glycoprotein transports cortisol, aldosterone, and dexamethasone, but not progesterone. J Biol Chem (1992) 2.14
Frequent amplification of the c-met gene in scirrhous type stomach cancer. Biochem Biophys Res Commun (1992) 2.11
Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts. Cancer Res (1993) 2.03
Vasoactive intestinal polypeptide-induced chloride secretion by a colonic epithelial cell line. Direct participation of a basolaterally localized Na+,K+,Cl- cotransport system. J Clin Invest (1985) 2.01
Design issues addressed in published evaluations of adolescent HIV-risk reduction interventions: a review. J Adolesc Health (1996) 1.95
Regulation of peripheral lymph node genesis by the tumor necrosis factor family member TRANCE. J Exp Med (2000) 1.93
Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma. Int J Cancer (1994) 1.85
On the mechanism of action of ACTH. Recent Prog Horm Res (1971) 1.81
Her4 mediates ligand-dependent antiproliferative and differentiation responses in human breast cancer cells. Mol Cell Biol (2001) 1.80
Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine. Endocr Relat Cancer (2011) 1.78
Expression of interleukin-8 correlates with vascularity in human gastric carcinomas. Am J Pathol (1998) 1.75
Contralateral papillary thyroid cancer is frequent at completion thyroidectomy with no difference in low- and high-risk patients. Thyroid (2001) 1.73
Blockade of epidermal growth factor receptor function by bivalent and monovalent fragments of 225 anti-epidermal growth factor receptor monoclonal antibodies. Cancer Res (1993) 1.70
Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol (1994) 1.65
Apoptosis induced by an anti-epidermal growth factor receptor monoclonal antibody in a human colorectal carcinoma cell line and its delay by insulin. J Clin Invest (1995) 1.61
A functional role of cholinergic innervation to neurons in the cat visual cortex. J Neurophysiol (1987) 1.59
A monoclonal antibody against the c-erbB-2 protein enhances the cytotoxicity of cis-diamminedichloroplatinum against human breast and ovarian tumor cell lines. Cancer Res (1991) 1.58
Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies. J Natl Cancer Inst (1993) 1.56
Surgery plus adjuvant chemotherapy for T1-3N0M0 small-cell lung cancer. Rationale for current approach. Am J Clin Oncol (1991) 1.56
Hormonal control of human colon carcinoma cell growth in serum-free medium. Proc Natl Acad Sci U S A (1980) 1.55
Synthesis, stereochemistry, and structure-related properties of alpha, beta, gamma, delta-tetraphenylporphinatoiron(II). J Am Chem Soc (1975) 1.55
Effect of cadmium on estrogen receptor levels and estrogen-induced responses in human breast cancer cells. J Biol Chem (1994) 1.53
RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC). Clin Endocrinol (Oxf) (2011) 1.52
Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci U S A (1991) 1.52
Thymic carcinoma: a report of 13 cases. Eur J Surg Oncol (2001) 1.52
Real-time elastosonography: useful tool for refining the presurgical diagnosis in thyroid nodules with indeterminate or nondiagnostic cytology. J Clin Endocrinol Metab (2010) 1.50
Lower levels of TSH are associated with a lower risk of papillary thyroid cancer in patients with thyroid nodular disease: thyroid autonomy may play a protective role. Endocr Relat Cancer (2009) 1.49
Cell cycle and adhesion defects in mice carrying a targeted deletion of the integrin beta4 cytoplasmic domain. EMBO J (1998) 1.49
Funiculosin, a new antibiotic. I. Isolation, biological and chemical properties (studies on antiviral and antitumor antibiotics. 8). J Antibiot (Tokyo) (1969) 1.45
Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens. Am J Clin Pathol (1991) 1.45
Length heterogeneity in the poly (adenylic acid) region of yeast messenger ribonucleic acid. Biochemistry (1974) 1.43
Plasma and tissue chromogranin in patients with adrenocortical adenomas. J Endocrinol Invest (2004) 1.42
Snail-associated epithelial-mesenchymal transition promotes oesophageal squamous cell carcinoma motility and progression. J Pathol (2008) 1.42
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study. J Natl Cancer Inst (1997) 1.41
Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol (1995) 1.40
Clinical features of vivax malaria. Am J Trop Med Hyg (2001) 1.39
High prevalence of serum apolipoprotein E4 isoprotein in rheumatoid arthritis patients with amyloidosis. Arthritis Rheum (1996) 1.39
Observation of an antimatter hypernucleus. Science (2010) 1.38
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy. Mol Med (2001) 1.37
Long terminal repeat enhancement of v-mos transforming activity: identification of essential regions. J Virol (1983) 1.36
Inhibition of replication in functional mouse adrenal tumor cells by adrenocorticotropic hormone mediated by adenosine 3':5'-cyclic monophosphate. Proc Natl Acad Sci U S A (1971) 1.34
Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem (2001) 1.31
RET/PTC rearrangements in thyroid nodules: studies in irradiated and not irradiated, malignant and benign thyroid lesions in children and adults. J Clin Endocrinol Metab (2001) 1.31
Combined clinical, thyroid ultrasound and cytological features help to predict thyroid malignancy in follicular and Hupsilonrthle cell thyroid lesions: results from a series of 505 consecutive patients. Clin Endocrinol (Oxf) (2007) 1.30
Mouse c-mos oncogene activation is prevented by upstream sequences. Proc Natl Acad Sci U S A (1984) 1.30
Cis-acting sequences that affect somatic hypermutation of Ig genes. Immunol Rev (1998) 1.28
An endothelin receptor (ETA) antagonist isolated from Streptomyces misakiensis. Biochem Biophys Res Commun (1991) 1.28
Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer (1995) 1.27
Epidermal growth factor receptor (EGFr) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer (1995) 1.27
Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach. Cancer (1996) 1.26
Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer (1999) 1.26
The dioxygen adduct of meso-tetraphenylporphyrinmanganese(II), a synthetic oxygen carrier. J Am Chem Soc (1976) 1.25
Different distribution of endothelin receptor subtypes in pulmonary tissues revealed by the novel selective ligands BQ-123 and [Ala1,3,11,15]ET-1. Biochem Biophys Res Commun (1992) 1.24
Telomerase activity in preneoplastic and neoplastic gastric and colorectal lesions. Clin Cancer Res (1995) 1.24
Nuclear factor-kappa B activation pathway in intestinal epithelial cells is a major regulator of chemokine gene expression and neutrophil migration induced by Bacteroides fragilis enterotoxin. Clin Exp Immunol (2002) 1.24
Factors in successful resuscitation by paramedics. JACEP (1977) 1.20
Genetic and epigenetic alterations in multistep carcinogenesis of the stomach. J Gastroenterol (2000) 1.20
Somatic hypermutation of immunoglobulin genes is linked to transcription. Curr Top Microbiol Immunol (1998) 1.20
Expression of the E2F family in human gastrointestinal carcinomas. Int J Cancer (1999) 1.20
Bcl-2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer. Br J Cancer (1995) 1.19
A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. Br J Cancer (2002) 1.19
Telomerase activity and hTERT mRNA expression in glial tumors. Int J Oncol (2006) 1.18
Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas. Jpn J Cancer Res (1997) 1.18
Molecular diagnosis of gastric cancer: present and future. Gastric Cancer (2001) 1.18
Haemoglobin A1c (HbA1C) in non-diabetic and diabetic vascular patients. Is HbA1C an independent risk factor and predictor of adverse outcome? Eur J Vasc Endovasc Surg (2006) 1.18
Co-expression of osteopontin and CD44v9 in gastric cancer. Int J Cancer (1998) 1.18
A positive regulatory role for Cbl family proteins in tumor necrosis factor-related activation-induced cytokine (trance) and CD40L-mediated Akt activation. J Biol Chem (2001) 1.17
Expression of TGF-beta and procollagen type I and type III in human gastric carcinomas. Int J Cancer (1989) 1.17
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog (1992) 1.17
Measurement of direct photon production in p+p collisions at sqrt[s] = 200 GeV. Phys Rev Lett (2007) 1.16
In vitro biological profile of a highly potent novel endothelin (ET) antagonist BQ-123 selective for the ETA receptor. J Cardiovasc Pharmacol (1992) 1.15
Increased erbB-2 gene copies and expression in multiple stages of breast cancer. Cancer Res (1990) 1.15
Male sex, single nodularity, and young age are associated with the risk of finding a papillary thyroid cancer on fine-needle aspiration cytology in a large series of patients with nodular thyroid disease. Eur J Endocrinol (2010) 1.15
Sequences upstream from the mouse c-mos oncogene may function as a transcription termination signal. DNA (1986) 1.14
Interaction between epidermal growth factor and its receptor in progression of human gastric carcinoma. Int J Cancer (1988) 1.14
Relation of serum sialic acid to lipid concentrations. BMJ (1992) 1.13
Survival of coxsackievirus B3 under diverse environmental conditions. Appl Environ Microbiol (1979) 1.13
Autocrine action of amphiregulin in a colon carcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol (1992) 1.13
Overexpression of RII beta regulatory subunit of protein kinase A in human colon carcinoma cell induces growth arrest and phenotypic changes that are abolished by site-directed mutation of RII beta. Eur J Biochem (1996) 1.12
Transforming growth factor-alpha: an oncodevelopmental growth factor. Cancer Cells (1990) 1.12
Is elastography actually useful in the presurgical selection of thyroid nodules with indeterminate cytology? J Clin Endocrinol Metab (2011) 1.11
Chronic estrogen treatment increases levels of endothelial nitric oxide synthase protein in rat cerebral microvessels. Stroke (1999) 1.11
High PRL-3 expression in human gastric cancer is a marker of metastasis and grades of malignancies: an in situ hybridization study. Virchows Arch (2007) 1.10
Frequent p53 gene mutations in serrated adenomas of the colorectum. J Pathol (1998) 1.10